Philadelphia Inquirer: "Precision medicine addresses the unique characteristics of patients at the level of their genes and metabolism in a way that hasn't been done historically in medicine," said Lankenau Institute president and CEO George C. Prendergast, who will be a panelist at Cancer Precision Medicine, Big Ideas in Research, Treatment and Prevention, a half-day public conference Thursday presented by The Inquirer and the American Association for Cancer Research.
Promise of precision
About Lankenau Institute for Medical Research
Lankenau Institute for Medical Research (LIMR) is a nonprofit biomedical research institute located on the campus of Lankenau Medical Center and is part of Main Line Health. Founded in 1927, LIMR’s mission is to improve human health and well-being. Faculty and staff are devoted to advancing innovative new approaches to formidable medical challenges, including cancer, cardiovascular disease, gastrointestinal disorders and autoimmune diseases, such as diabetes and arthritis. LIMR’s principal investigators conduct basic, preclinical and translational research, using their findings to explore ways to improve disease detection, diagnosis, treatment and prevention. They are committed to extending the boundaries of human health through technology transfer and training of the next generation of scientists and physicians.